TY - JOUR
T1 - Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice
AU - Linden, Albert G.
AU - Li, Shili
AU - Choi, Hwa Y.
AU - Fang, Fei
AU - Fukasawa, Masashi
AU - Uyeda, Kosaku
AU - Hammer, Robert E
AU - Horton, Jay D
AU - Engelking, Luke
AU - Liang, Guosheng
N1 - Funding Information:
This work was supported by National Institutes of Health Grants HL20948, 5K08DK102652 (L.J.E.), and ST32GM08014 (A.G.L., Medical Scientist Training Program Grant) and Foundation for the National Institutes of Health Grant 5T35OD010991 (H.Y.C., National Institutes of Health T35 Program). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no related financial interests to declare. Author’s Choice—Final version free via Creative Commons CC-BY license. Manuscript received 9 November 2017 and in revised form 2 January 2018. Published, JLR Papers in Press, January 15, 2018 DOI https://doi.org/10.1194/jlr.M081836
Publisher Copyright:
© 2018 American Society for Biochemistry and Molecular Biology Inc.. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Lipogenesis in liver is highest in the postprandial state; insulin activates SREBP-1c, which transcriptionally activates genes involved in FA synthesis, whereas glucose activates carbohydrate-responsive element-binding protein (ChREBP), which activates both glycolysis and FA synthesis. Whether SREBP-1c and ChREBP act independently of one another is unknown. Here, we characterized mice with liverspecific deletion of ChREBP (L-Chrebp-/- mice). Hepatic ChREBP deficiency resulted in reduced mRNA levels of glycolytic and lipogenic enzymes, particularly in response to sucrose refeeding following fasting, a dietary regimen that elicits maximal lipogenesis. mRNA and protein levels of SREBP-1c, a master transcriptional regulator of lipogenesis, were also reduced in L-Chrebp-/- livers. Adenoassociated virus-mediated restoration of nuclear SREBP-1c in L-Chrebp-/- mice normalized expression of a subset of lipogenic genes, while not affecting glycolytic genes. Conversely, ChREBP overexpression alone failed to support expression of lipogenic genes in the livers of mice lacking active SREBPs as a result of Scap deficiency. Together, these data show that SREBP-1c and ChREBP are both required for coordinated induction of glycolytic and lipogenic mRNAs. Whereas SREBP-1c mediates insulin's induction of lipogenic genes, ChREBP mediates glucose's induction of both glycolytic and lipogenic genes. These overlapping, but distinct, actions ensure that the liver synthesizes FAs only when insulin and carbohydrates are both present.
AB - Lipogenesis in liver is highest in the postprandial state; insulin activates SREBP-1c, which transcriptionally activates genes involved in FA synthesis, whereas glucose activates carbohydrate-responsive element-binding protein (ChREBP), which activates both glycolysis and FA synthesis. Whether SREBP-1c and ChREBP act independently of one another is unknown. Here, we characterized mice with liverspecific deletion of ChREBP (L-Chrebp-/- mice). Hepatic ChREBP deficiency resulted in reduced mRNA levels of glycolytic and lipogenic enzymes, particularly in response to sucrose refeeding following fasting, a dietary regimen that elicits maximal lipogenesis. mRNA and protein levels of SREBP-1c, a master transcriptional regulator of lipogenesis, were also reduced in L-Chrebp-/- livers. Adenoassociated virus-mediated restoration of nuclear SREBP-1c in L-Chrebp-/- mice normalized expression of a subset of lipogenic genes, while not affecting glycolytic genes. Conversely, ChREBP overexpression alone failed to support expression of lipogenic genes in the livers of mice lacking active SREBPs as a result of Scap deficiency. Together, these data show that SREBP-1c and ChREBP are both required for coordinated induction of glycolytic and lipogenic mRNAs. Whereas SREBP-1c mediates insulin's induction of lipogenic genes, ChREBP mediates glucose's induction of both glycolytic and lipogenic genes. These overlapping, but distinct, actions ensure that the liver synthesizes FAs only when insulin and carbohydrates are both present.
UR - http://www.scopus.com/inward/record.url?scp=85042917855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042917855&partnerID=8YFLogxK
U2 - 10.1194/jlr.M081836
DO - 10.1194/jlr.M081836
M3 - Article
C2 - 29335275
AN - SCOPUS:85042917855
SN - 0022-2275
VL - 59
SP - 475
EP - 487
JO - Journal of lipid research
JF - Journal of lipid research
IS - 3
ER -